Trimel Pharmaceuticals Corporation

Trimel Pharmaceuticals Corporation

August 30, 2012 08:00 ET

Trimel to Present at the Upcoming Investor Conferences

TORONTO, ONTARIO--(Marketwire - Aug. 30, 2012) - Trimel Pharmaceuticals Corporation (TSX:TRL) (the "Company" or "Trimel") today announced that it will participate in the Stifel Nicolaus 2012 Healthcare Conference at the Four Seasons Hotel in Boston, MA on September 6th, 2012 at 4:25pm EDT and the Rodman and Renshaw 14th Annual Global Investment Conference at the Waldorf Astoria Hotel in New York, NY on September 10th, 2012 at 2:25pm EDT.

Mr. Kenneth Howling, Chief Financial Officer, is scheduled to present an overview of the Company at the upcoming conferences. The presentation materials will also be available on the Trimel website at

For further information regarding Trimel Pharmaceuticals Corporation, please contact Kenneth Howling, Chief Financial Officer at (416) 679-0536 or Trimel via email at

About Trimel

Trimel Pharmaceuticals Corporation (TSX:TRL) - Developing medications for Female Sexual Health and conditions related to Aging, and Well Being. Trimel is developing multiple product opportunities, including CompleoTRT™, a bio-adhesive intranasal Testosterone gel currently in Phase III clinical testing in the United States. CompleoTRT™ is under investigation for the treatment of male hypogonadism, a condition commonly referred to as "Low T". For more information, please visit

Contact Information